NASDAQ: TOMZ) New Era for Food Safety and Global Health - More Stock Under $1 Inside" src="https://www.abnewswire.com/upload/2025/09/1758718572.jpg" alt="TOMI Environmental (NASDAQ: TOMZ) New Era for Food Safety and Global Health - More Stock Under $1 Inside" width="225" height="225">

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a leader in disinfection and decontamination, announced a major regulatory milestone with the U.S. Food and Drug Administration (FDA). The FDA’s final rule, published September 3, 2025 (90 FR 42535), expands the permitted use of hydrogen peroxide as a secondary direct food additive under 21 CFR §173.356, provided residues are fully removed before consumer contact.

TOMI Environmental’s (NASDAQ: TOMZ), SteraMist® iHP® (ionized Hydrogen Peroxide) is already fully aligned with the updated framework. Produced from food-grade hydrogen peroxide and deionized water, SteraMist is energized into submicron particles that act like a gas, penetrating hard-to-reach surfaces to deliver a six-log kill rate (99.9999% pathogen reduction) with no detectable residue.

“The FDA’s action validates the foundation of our SteraMist technology and paves the way for food industry adoption,” said Elissa J. Shane, COO. “Independent studies confirm residues decompose quickly, ensuring safety for both producers and consumers.”

In addition to TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), keep an eye on: Datavault AI Inc, (NASDAQ: DVLT), Oriental Rise Inc (NASDAQ: ORIS), New Era Energy Inc. (NASDAQ: NUAI) and Innovation Beverage (NASDAQ: IBG) as they’re moving aggressively during early trading today!

Bonus Bunch: SHF Holdings Inc (NASDAQ: SHFS) CleanCore Solutions (NYSE: ZONE) Youxin Technology (NASDAQ: YAAS) Jiuzi Holdings Inc (NASDAQ: JZXN) Expion360 Inc (NASDAQ: XPON) Watch Now!

This regulatory expansion comes at a time when global health risks are intensifying. Infectious disease outbreaks have increased ten-fold versus pre-pandemic levels, spanning 44 countries and including high-impact threats such as SARS, MERS, COVID-19, avian influenza, resistant TB, and invasive bacterial infections. With international food supply chains amplifying exposure, preventive disinfection tools are vital for both public safety and economic resilience.

The FDA’s decision positions TOMI for significant industry growth. Beyond healthcare and life sciences, SteraMist now has expanded potential across food processing, storage, packaging, and transport, as well as in outbreak response and preventive pathogen control. Its speed, material compatibility, and residue-free performance give TOMI a strong competitive edge. With momentum building, the company’s 52-week high of $1.50 is now expected to be tested in the near future, reinforcing investor confidence.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com